Maria Linares
Overview
Explore the profile of Maria Linares including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
632
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Ancos-Pintado R, Bragado-Garcia I, Morales M, Garcia-Vicente R, Arroyo-Barea A, Rodriguez-Garcia A, et al.
Cancers (Basel)
. 2022 Jul;
14(15).
PMID: 35892871
CRISPR is becoming an indispensable tool in biological research, revolutionizing diverse fields of medical research and biotechnology. In the last few years, several CRISPR-based genome-targeting tools have been translated for...
12.
Jimenez-Martin J, Orozco-Saumell A, Hernando H, Linares M, Mariscal R, Lopez Granados M, et al.
ACS Sustain Chem Eng
. 2022 Jul;
10(27):8885-8896.
PMID: 35846797
Sn-USY materials have been prepared through an optimized post-synthetic catalytic metalation procedure. These zeolites displayed, upon ion exchange with alkaline metals, an outstanding activity in the direct transformation of glucose...
13.
14.
Garcia Delgado L, Postigo M, Cuadrado D, Gil-Casanova S, Martinez A, Linares M, et al.
PLoS One
. 2022 May;
17(5):e0268494.
PMID: 35587505
Worldwide, TB is one of the top 10 causes of death and the leading cause from a single infectious agent. Although the development and roll out of Xpert MTB/RIF has...
15.
Rodriguez-Garcia A, Linares M, Morales M, Allain-Maillet S, Mennesson N, Sanchez R, et al.
Front Immunol
. 2022 Jan;
12:797209.
PMID: 35087522
Multiple myeloma (MM) remains an incurable plasma cell malignancy. While its origin is enigmatic, an association with infectious pathogens including hepatitis C virus (HCV) has been suggested. Here we report...
16.
Ruiz-Heredia Y, Ortiz-Ruiz A, Samur M, Garrido V, Rufian L, Sanchez R, et al.
Cancers (Basel)
. 2021 Jul;
13(13).
PMID: 34202390
Many studies over the last 20 years have investigated the role of mitochondrial DNA (mtDNA) alterations in carcinogenesis. However, the status of the mtDNACN in MM and its implication in...
17.
Ortiz-Ruiz A, Ruiz-Heredia Y, Morales M, Aguilar-Garrido P, Garcia-Ortiz A, Valeri A, et al.
Cancers (Basel)
. 2021 Apr;
13(7).
PMID: 33916196
Mitochondria are involved in the development and acquisition of a malignant phenotype in hematological cancers. Recently, their role in the pathogenesis of multiple myeloma (MM) has been suggested to be...
18.
Rodriguez-Garcia A, Garcia-Vicente R, Morales M, Ortiz-Ruiz A, Martinez-Lopez J, Linares M
Antioxidants (Basel)
. 2020 Dec;
9(12).
PMID: 33271863
Among the different mechanisms involved in oxidative stress, protein carbonylation and lipid peroxidation are both important modifications associated with the pathogenesis of several diseases, including cancer. Hematopoietic cells are particularly...
19.
Onecha E, Rapado I, Morales M, Carreno-Tarragona G, Martinez-Sanchez P, Gutierrez X, et al.
Haematologica
. 2020 Aug;
106(9):2325-2333.
PMID: 32732356
In cases of treatment failure in acute myeloid leukemia (AML), the utility of mutational profiling in primary refractoriness and relapse is not established. We undertook a perspective study using next-generation...
20.
Onecha E, Ruiz-Heredia Y, Martinez-Cuadron D, Barragan E, Martinez-Sanchez P, Linares M, et al.
Br J Haematol
. 2020 Feb;
189(4):672-683.
PMID: 32068246
Refractoriness to induction therapy and relapse after complete remission are the leading causes of death in patients with acute myeloid leukaemia (AML). This study focussed on the prediction of response...